Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujuan Du

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Cell Research|November 27, 2021
Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2Yunqing Gu, Jun Cao, Xinyu Zhang, et al.
Cell Research|April 2, 2022
Author Correction: Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2Yunqing Gu, Jun Cao, Xinyu Zhang, et al.
Signal Transduction and Targeted Therapy|November 4, 2021
A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variantsZhenlin Yang, Yulu Wang, Yujia Jin, et al.
Nature Microbiology|June 30, 2022
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Cell Research|November 27, 2021
Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2Yunqing Gu, Jun Cao, Xinyu Zhang, et al.
Cell Research|April 2, 2022
Author Correction: Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2Yunqing Gu, Jun Cao, Xinyu Zhang, et al.
Signal Transduction and Targeted Therapy|November 4, 2021
A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variantsZhenlin Yang, Yulu Wang, Yujia Jin, et al.
Nature Microbiology|June 30, 2022
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu, et al.
Pageof 4